Imunon (IMNN) Interest Expenses (2010 - 2026)
Imunon's (IMNN) quarterly Interest Expenses came in at $121384.0 in Q1 2026, down 26.54% YoY from $165231.0 in Q1 2025, and up 2.55% on a QoQ basis from $118360.0 in Q4 2025.
Imunon (IMNN) Interest Expenses (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Interest Expenses data on file, last reported at $121384.0 in Q1 2026.
- Quarterly Interest Expenses fell 26.54% year-over-year to $121384.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $543251.0 (up 74.46% YoY) and the FY2025 annual result came in at $76.8 million, up 3718.44% from the prior year.
- Interest Expenses rose to $121384.0 in Q1 2026, from $118360.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $4.4 million in Q4 2022 to a low of -$154670.0 in Q4 2023.
- A 5-year average of $483605.5 and a median of $162545.0 in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses soared 2839.46% — and 2023, when it slumped 103.52%.
- Tracing IMNN's Interest Expenses over 5 years: stood at $4.4 million in 2022, then tumbled by 103.52% to -$154670.0 in 2023, then surged by 189.4% to $138276.0 in 2024, then fell by 14.4% to $118360.0 in 2025, then rose by 2.55% to $121384.0 in 2026.
- The last three Interest Expenses figures came in at $121384.0 (Q1 2026), $118360.0 (Q4 2025), and $154767.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 892,940.00 |
| Jun 30, 2026 | 892,940.00 |
| Mar 31, 2026 | 121,384.00 |
| Mar 31, 2026 | 121,384.00 |
| Dec 31, 2025 | 118,360.00 |
| Dec 31, 2025 | 118,360.00 |
| Sep 30, 2025 | 154,767.00 |
| Sep 30, 2025 | 154,767.00 |
| Jun 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 165,231.00 |
| Mar 31, 2025 | 165,231.00 |
| Dec 31, 2024 | 138,276.00 |
| Dec 31, 2024 | 138,276.00 |
| Sep 30, 2024 | 370,236.00 |
| Sep 30, 2024 | 370,236.00 |
| Jun 30, 2024 | 370,236.00 |
| Jun 30, 2024 | 370,236.00 |
| Mar 31, 2024 | 162,545.00 |
| Mar 31, 2024 | 162,545.00 |